Michael Antoniou

Principal Investigator; reseach group leadrt and lecturer

King’s College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Michael Antoniou is a Principal Investigator, research group leader, and lecturer at King's College London. His research focuses on gene therapy for β-Thalassemia, the implications of agricultural GMOs and their associated pesticides, and the effects of prenatal exposure to glyphosate and its mixtures. Recent publications highlight his work on evaluating therapeutic vectors and assessing cytotoxicity mechanisms of herbicide ingredients.

Articles (7)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2020

Collaborators (2)

Aristides Tsatsakis

GREECE

View details

PARASKEVI-MARIA NECHALIOTI

University of Thessaly

GREECE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michael Antoniou

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

Agricultural GMOs and their associated pesticides: misinformation, science, and evidence

Evaluation of perinatal exposure of glyphosate and its mixture with 2,4-D and dicamba οn liver redox status in Wistar rats

The GlyphoMix protocol: Multiorgan changes in rats caused by prenatal exposure to glyphosate or its mixture with 2,4-D and dicamba

Evaluation of Mono- and Bi-Functional GLOBE-Based Vectors for Therapy of β-Thalassemia by <i>HBB<sup>AS3</sup></i> Gene Addition and Mutation-Specific RNA Interference

The surfactant co-formulant POEA in the glyphosate-based herbicide RangerPro but not glyphosate alone causes necrosis in Caco-2 and HepG2 human cell lines and ER stress in the ToxTracker assay

Cytotoxicity Mechanisms of Eight Major Herbicide Active Ingredients in Comparison to Their Commercial Formulations

Relative and Absolute Quantification of Aberrant and Normal Splice Variants in HBBIVSI−110 (G > A) β-Thalassemia

Collaborators (2)

Aristides Tsatsakis

PARASKEVI-MARIA NECHALIOTI

Make your next move.